Bdh Industries Ltd vs Supriya Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of BDH Industries Ltd is ₹ 377.35 as of 30 Apr 15:30 . The P/E Ratio of BDH Industries Ltd changed from 8.6 on March 2021 to 16.3 on March 2025 . This represents a CAGR of 13.64% over 5 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 31.4 on March 2025 . This represents a CAGR of 4.73% over 4 years The Market Cap of BDH Industries Ltd changed from ₹ 53.19 crore on March 2021 to ₹ 151.46 crore on March 2025 . This represents a CAGR of 23.28% over 5 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 3967 crore on March 2022 to ₹ 5903 crore on March 2025 . This represents a CAGR of 10.45% over 4 years The revenue of BDH Industries Ltd for the Dec '25 is ₹ 29.87 crore as compare to the Sep '25 revenue of ₹ 19.51 crore. This represent the growth of 53.1% The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 209.05 crore as compare to the Sep '25 revenue of ₹ 202.56 crore. This represent the growth of 3.2% The ebitda of BDH Industries Ltd for the Dec '25 is ₹ 4.76 crore as compare to the Sep '25 ebitda of ₹ 3.88 crore. This represent the growth of 22.68% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 74.24 crore as compare to the Sep '25 ebitda of ₹ 75.37 crore. This represent the decline of -1.5% The net profit of BDH Industries Ltd changed from ₹ 1.57 crore to ₹ 3.49 crore over 7 quarters. This represents a CAGR of 57.85% The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 49.68 crore over 7 quarters. This represents a CAGR of 6.30% The Dividend Payout of BDH Industries Ltd changed from 28.02 % on March 2021 to 27.96 % on March 2025 . This represents a CAGR of -0.04% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .

About BDH Industries Ltd

Incorporated in 1990 as a private limited company, BDH Industries Limited (BDHIL) was converted into a public limited company in 1994.
It was established to takeover a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals and Renewable Energy segments.
BDH offers a full range of Oral Solid Dosages (OSD) technologies.
Research &Development Centre at Kandivali, Mumbai, undertake formulation development projects on new Novel Drug Delivery System (NDDS). It came out with a public issue in Feb.'95, aggregating Rs 6.

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

FAQs for the comparison of BDH Industries Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, BDH Industries Ltd or Supriya Lifescience Ltd?

Market cap of BDH Industries Ltd is 217 Cr while Market cap of Supriya Lifescience Ltd is 5,589 Cr

What are the key factors driving the stock performance of BDH Industries Ltd and Supriya Lifescience Ltd?

The stock performance of BDH Industries Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BDH Industries Ltd and Supriya Lifescience Ltd?

As of May 4, 2026, the BDH Industries Ltd stock price is INR ₹377.35. On the other hand, Supriya Lifescience Ltd stock price is INR ₹694.5.

How do dividend payouts of BDH Industries Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of BDH Industries Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.